Patents Assigned to Syntropharma Limited
  • Pharmaceutical compositions for treatment of addiction
    Patent number: 9700552
    Abstract: The invention provides transdermal patches comprising an adhesive and a composition comprising naltrexone and either methyl oleate or isopropyl myristate, a kit comprising a plurality of such transdermal patches, a composition comprising naltrexone and methyl oleate, such a composition for use as a medicament, and compositions comprising naltrexone and methyl oleate or isopropyl myristate for use in the treatment of alcoholism or opiate addiction.
    Type: Grant
    Filed: February 26, 2009
    Date of Patent: July 11, 2017
    Assignee: Syntropharma Limited
    Inventor: Ludwig Jan Weimann
  • PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF ADDICTION
    Publication number: 20110064788
    Abstract: The invention provides transdermal patches comprising an adhesive and a composition comprising naltrexone and either methyl oleate or isopropyl myristate, a kit comprising a plurality of such transdermal patches, a composition comprising naltrexone and methyl oleate, such a composition for use as a medicament, and compositions comprising naltrexone and methyl oleate or isopropyl myristate for use in the treatment of alcoholism or opiate addiction.
    Type: Application
    Filed: February 26, 2009
    Publication date: March 17, 2011
    Applicant: Syntropharma Limited
    Inventor: Ludwig Jan Weimann